AMPLITUDE SURGICAL
Acquired by
ZYDUS
AMPLITUDE SURGICAL acquired by ZYDUS
Target
AMPLITUDE SURGICAL
Acquirer
ZYDUS
Context
Zydus entered into exclusive negotiations to acquire a controlling 85.6% stake (block trade) in Amplitude Surgical from PAI Partners, the management and minority shareholders. The offer price is EUR6.25 per share, representing an 80.6% premium over the pre-announcement share price. Following the block acquisition, Zydus will launch a mandatory simplified tender offer (OPAS) to acquire the remaining shares and intends to delist the company (squeeze-out) if the 90% threshold is reached.
AMPLITUDE SURGICAL, which reported an EBITDA margin of LOGIN in 2024, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN premium to the 13.4x average currently observed in the Healthcare & Pharma sector.
Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.
-> Deep-dive in Healthcare & Pharma market trends
Target
Amplitude Surgical is a leading French MedTech company specializing in the design and manufacture of high-end orthopedic implants for lower-limb surgery (primarily Hip and Knee). Founded in 1997 in Valence, the group positions itself as a premium player, differentiating through a strong technological ecosystem that includes the AMPLIVISION computer-assisted navigation system and the i.M.A.G.E. single-use instrumentation platform. Following the strategic divestment of its foot and ankle division (Novastep) in 2023, the company refocused entirely on its core hip and knee segments, where it holds a strong #2 market position in France.
Ent. Value
LOGIN
Equity Value
LOGIN
Multiples Analysis
EV / Revenue
LOGIN
EV / EBITDA
LOGIN
EV / EBIT
LOGIN
Historical Financials (EUR)
Other operations with AMPLITUDE SURGICAL
mynth data is contributed by M&A / PE professionals and systematically cross-verified against private deal documents and official releases. All source materials are destroyed post-validation to guarantee data anonymity and compliance.